{"id":"W3089157576","doi":"10.1016/j.ejca.2020.08.021","title":"Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"AstraZeneca","keywords":"Medicine; Olaparib; Response Evaluation Criteria in Solid Tumors; Internal medicine; Concordance; Oncology; Progression-free survival; Placebo; Ovarian cancer; Cancer; Chemotherapy; Progressive disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001822386,0.0002428984,0.001152305,0.0003057037,0.0002702291,0.0008714657,0.0004295533,0.0005807664,0.0009361895],"category_scores_gemma":[0.003391184,0.0002331934,0.0008042231,0.000450051,0.0002843156,0.000475397,0.0003246261,0.000788098,0.0001339498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006114288,"about_ca_system_score_gemma":0.0003789949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008184271,"about_ca_topic_score_gemma":0.001885337,"domain_scores_codex":[0.9990263,0.000473489,0.00007752603,0.0002314471,0.0001011608,0.00009011318],"domain_scores_gemma":[0.9982344,0.0008316536,0.0004244403,0.0001535211,0.0001129541,0.0002430283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1352943,0.0005294275,0.801562,0.0002992781,0.002817368,0.0003408589,0.0004237138,0.002348273,0.005004366,0.0001885445,0.001864833,0.04932706],"study_design_scores_gemma":[0.005639424,0.009967169,0.9743029,0.0000632147,0.001574777,0.0006852096,0.0001605135,0.003686853,0.001187505,0.0003403605,0.002346535,0.00004554353],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981184,0.000859239,0.00005106541,0.00009170399,0.00002348537,0.00001974768,0.0002402797,0.000007052286,0.0005890678],"genre_scores_gemma":[0.9989648,0.0001222577,0.00005905498,0.00008182186,0.00002393268,0.00001668476,0.0005568101,0.000004621465,0.000169928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001822386,"threshold_uncertainty_score":0.009637773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01869387253935158,"score_gpt":0.3029631482047462,"score_spread":0.2842692756653946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}